GE published a regulatory filing about the spinoff of its healthcare unit, which it expects to complete in the first week of 2023, if the transaction is approved by its board of directors. GE HealthCare will be listed on the Nasdaq under the ticker “GEHC.”

QuidelOrtho on Wednesday reported preliminary third quarter revenues of between $782 million and $785 million.

Illumina said on Tuesday that it has entered into a strategic research collaboration with AstraZeneca on drug target discovery.

Amoy (300685.SZ) and Beigene (NASDAQ: BGNE, HKEX: 06160, SSE: 688235) have recently entered into a strategic collaboration on companion diagnostics.

Beckman Coulter Diagnostics said Tuesday that it has acquired StoCastic, a startup informatics company that develops artificial intelligence-based clinical decision support for hospital emergency departments. Financial terms were not disclosed.

Wall Street had a mixed reaction to a report that Bio-Rad Laboratories and Qiagen are in talks about a possible merger.

September 21, Merck, a leading global technology company, announced the opening of the first phase of its EUR 29 million biosafety testing laboratory in China, a virus clearance validation laboratory. The 5,000 square meter center is Merck's first laboratory of its kind in China.

Cytiva, backed by a $1.5 billion investment from its parent company, the Danaher Group, continued its expansion tear with the acquisition of CEVEC Pharmaceuticals.

Thermo Fisher Scientific said on Monday that it has received CE-IVD marking for its TaqPath Enteric Bacterial Select Panel, a PCR-based assay developed to detect common gastrointestinal (GI) bacteria.

Before the Chinese National Day holiday, NINGBO SCIENTZ Biotechnology announced that the company will be listed on the Beijing Stock Exchange on October 10, 2022. The issue price of NINGBO SCIENTZ Biotechnology is 15 CNY per share, and the issue price-earnings ratio is 30.12 times.

The US Food and Drug Administration said Friday it has granted Emergency Use Authorization for Abbott's real-time PCR monkeypox test, the Alinity m MPXV assay.

Roche has named the next CEO for its diagnostics efforts, as its prior division chief, Thomas Schinecker, is waiting in the wings to head up the Big Pharma overall starting next March.

On September 28, a series of activities for the 110th anniversary of Peking University's Medical Education, "the Collective Signing Ceremony of the University-Enterprise Joint Research & Development Platform", was held.

Taiwan-based diagnostic firm Micronbrane Medical announced on Wednesday that it raised $4.5 million in a Series A funding round.

Illumina Inc (ILMN.O), the top maker of DNA sequencers used to speed drug development and other research, on Thursday announced the launch of its next-generation NovaSeq X systems, which it said can generate more than 20,000 whole genomes per year, or 2.5 times that of prior sequencers.